Kuldip J Behniwal, MD
Urology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 52 years
- Graduated 1974
Offices
1 location · Urology Associates of Central California Medical Group Inc · 11 clinicians in this group
Looking this up.
Hospitals listed: 058233 · Clovis Community Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Behniwal’s office at (559) 321-2800 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$694,761
Medicare paid this office $694,761 for 1,115 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 820 | $102,892 | $69 |
| Diagnostic exam of bladder and urethra using an endoscope | 176 | $38,666 | $196 |
| Return visit (30+ min) | 357 | $36,203 | $89 |
| Leuprolide injectable, camcevi, 1 mg | 13 | $34,114 | None |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 11 | $32,331 | $703 |
See all 43 services
| Short return visit (20+ min) | 820 | $102,892 | $69 |
| Diagnostic exam of bladder and urethra using an endoscope | 176 | $38,666 | $196 |
| Return visit (30+ min) | 357 | $36,203 | $89 |
| Leuprolide injectable, camcevi, 1 mg | 13 | $34,114 | None |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 11 | $32,331 | $703 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 20 | $20,829 | None |
| Ultrasound measurement of bladder capacity after voiding | 869 | $13,642 | $9 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 54 | $13,634 | $49 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 13 | $13,330 | $1,025 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 45 | $10,770 | $51 |
| New patient visit (45+ min) | 84 | $9,769 | $116 |
| New patient visit (30+ min) | 96 | $7,790 | $81 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 24 | $7,423 | $285 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 415 | $6,133 | $12 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 41 | $5,670 | $39 |
| Ultrasound scan of pelvic region through rectum | 51 | $5,527 | $108 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 18 | $4,982 | $277 |
| Ct scan of abdomen and pelvis before and after contrast | 18 | $4,930 | $274 |
| Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 39 | $4,161 | $38 |
| Insertion of needle into vein for collection of blood sample | 354 | $3,811 | $8 |
| Automated urinalysis test | 888 | $3,709 | $2 |
| X-ray of body plane | 37 | $3,310 | $69 |
| Dilation of urethra using an endoscope | 11 | $3,218 | $268 |
| Injection of drug or substance under skin or into muscle | 103 | $3,009 | $12 |
| Insertion of device into abdomen with pressure and urine flow rate study | 18 | $2,859 | $159 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 40 | $2,769 | $29 |
| Bcg live intravesical instillation, 1 mg | 11 | $2,742 | None |
| Simple measurement of pressure of urine flow in bladder | 14 | $2,680 | $179 |
| Complete ultrasound scan behind abdominal cavity | 27 | $2,352 | $87 |
| Simple insertion of temporary bladder tube | 22 | $2,272 | $50 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 17 | $2,201 | $110 |
| Cell examination of specimen, concentration technique | 55 | $2,164 | $33 |
| Simple bladder irrigation and/or instillation | 11 | $1,959 | $63 |
| Instillation of anti-cancer drug into bladder | 12 | $1,818 | $73 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 17 | $1,538 | $59 |
| Short return visit | 25 | $1,207 | $46 |
| X-ray of abdomen, 1 view | 37 | $1,168 | $23 |
| Injection, tobramycin sulfate, up to 80 mg | 85 | $582 | None |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 18 | $471 | $26 |
| Electronic assessment of bladder emptying | 76 | $461 | $6 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 18 | $200 | $0 |
| Injection, ketorolac tromethamine, per 15 mg | 17 | $33 | None |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $16 | None |
Procedures Medicare counted
| Prostate resection | 15 | More than 70% of doctors who do this |
| Removal of tissue | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | 2,141 | 1,410 | 1,482 | 1,334 | 1,213 | 1,544 |
| Diagnostic exam of bladder and urethra using an endoscope | 308 | 303 | 275 | 272 | 222 | 197 |
| Electronic assessment of bladder emptying | 155 | 143 | 128 | 124 | 92 | 80 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 122 | 104 | 78 | 59 | – | 46 |
| Simple insertion of temporary bladder tube | 38 | 27 | 32 | 20 | 25 | 45 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 57 | 40 | 38 | 15 | 13 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,115 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 15% · Women 26% · Also on Medicaid 32% · Health risk score 1.37. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Diabetes 47% · Coronary heart disease 40% · Chronic kidney disease 36% · Cancer 25% · Heart failure 22% · Atrial fibrillation 18% · COPD 16% · Depression 15% · Stroke 9% · Dementia 7%.
The office billed $2,026,808, Medicare allowed $896,589 and paid $694,761; for 58,074 services of 94 kinds; $302,290 of it was for drugs given in the office and $392,471 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,115 | 58,074 | 76 | 1.37 | $2,026,808 | $694,761 |
| 2023 | 1,108 | 56,301 | 75 | 1.32 | $1,399,985 | $471,764 |
| 2022 | 1,209 | 73,643 | 75 | 1.32 | $1,734,532 | $622,101 |
| 2021 | 1,265 | 81,335 | 75 | 1.34 | $2,285,397 | $822,207 |
| 2020 | 1,312 | 89,403 | 75 | 1.42 | $2,856,488 | $993,860 |
| 2019 | 1,520 | 96,221 | 75 | 1.44 | $2,642,573 | $882,427 |
| 2018 | 1,466 | 108,377 | 74 | 1.53 | $2,052,062 | $705,759 |
| 2017 | 1,465 | 84,420 | 74 | 1.47 | $2,195,279 | $719,931 |
| 2016 | 1,455 | 94,177 | 74 | 1.46 | $1,995,614 | $635,370 |
| 2015 | 1,349 | 104,236 | 74 | 1.48 | $1,805,489 | $599,871 |
| 2014 | 1,442 | 25,952 | 74 | 1.34 | $1,906,911 | $624,631 |
| 2013 | 1,377 | 30,057 | 73 | 1.38 | $2,132,042 | $765,367 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 32 services
| Short return visit (20+ min) | 872 | $101,861 | $66 |
| Diagnostic exam of bladder and urethra using an endoscope | 204 | $44,352 | $200 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 37 | $36,300 | None |
| Return visit (30+ min) | 261 | $29,897 | $101 |
| New patient visit (45+ min) | 217 | $27,055 | $125 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 13 | $18,895 | $1,453 |
| Ct scan of abdomen and pelvis before and after contrast | 42 | $12,843 | $306 |
| Ultrasound measurement of bladder capacity after voiding | 747 | $10,296 | $8 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 26 | $7,722 | $297 |
| X-ray of body plane | 65 | $6,804 | $73 |
| Simple measurement of pressure of urine flow in bladder | 25 | $5,904 | $184 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 19 | $5,723 | $301 |
| Ultrasound scan of pelvic region through rectum | 45 | $4,697 | $104 |
| Insertion of needle into vein for collection of blood sample | 399 | $4,267 | $8 |
| Automated urinalysis test | 977 | $4,080 | $2 |
| Cell examination of specimen, concentration technique | 96 | $4,020 | $35 |
| Dilation of urethra using an endoscope | 13 | $3,579 | $275 |
| Insertion of device into abdomen with pressure and urine flow rate study | 21 | $3,508 | $167 |
| Bcg live intravesical instillation, 1 mg | 12 | $2,930 | None |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $2,846 | $29 |
| Complete ultrasound scan behind abdominal cavity | 31 | $2,624 | $85 |
| Injection of drug or substance under skin or into muscle | 91 | $2,596 | $12 |
| Instillation of anti-cancer drug into bladder | 15 | $2,365 | $74 |
| X-ray of abdomen, 1 view | 65 | $2,299 | $24 |
| Simple insertion of temporary bladder tube | 14 | $1,267 | $51 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 21 | $564 | $27 |
| Injection, testosterone cypionate, 1 mg | 13 | $555 | None |
| Electronic assessment of bladder emptying | 92 | $535 | $6 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 44 | $497 | $0 |
| Injection, tobramycin sulfate, up to 80 mg | 68 | $405 | None |
| Injection, ketorolac tromethamine, per 15 mg | 23 | $38 | None |
| Injection, ceftriaxone sodium, per 250 mg | 12 | $32 | None |
2022: 42 services
| Short return visit (20+ min) | 1,023 | $136,090 | $66 |
| Injection, denosumab, 1 mg | 13 | $96,866 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 244 | $55,657 | $205 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 46 | $47,910 | None |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 15 | $46,216 | $783 |
| New patient visit (45+ min) | 251 | $31,024 | $124 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 15 | $22,672 | $1,511 |
| Ct scan of abdomen and pelvis before and after contrast | 62 | $18,822 | $304 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 15 | $17,269 | $1,151 |
| Ultrasound measurement of bladder capacity after voiding | 817 | $10,891 | $8 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 32 | $10,734 | $335 |
| Return visit (30+ min) | 98 | $10,478 | $97 |
| Simple measurement of pressure of urine flow in bladder | 33 | $7,924 | $193 |
| Ultrasound scan of pelvic region through rectum | 65 | $7,166 | $110 |
| Injection, degarelix, 1 mg | 11 | $7,159 | None |
| X-ray of body plane | 61 | $5,579 | $71 |
| Insertion of device into abdomen with pressure and urine flow rate study | 32 | $5,565 | $174 |
| Automated urinalysis test | 1,055 | $4,639 | $2 |
| Complete ultrasound scan behind abdominal cavity | 46 | $3,859 | $84 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 50 | $3,601 | $29 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 11 | $3,514 | $319 |
| Cell examination of specimen, concentration technique | 84 | $3,411 | $34 |
| Injection of drug or substance under skin or into muscle | 120 | $3,272 | $12 |
| X-ray of abdomen, 1 view | 61 | $1,892 | $23 |
| Insertion of needle into vein for collection of blood sample | 424 | $1,823 | $3 |
| Psa (prostate specific antigen) measurement, total | 93 | $1,710 | $18 |
| Simple bladder irrigation and/or instillation | 11 | $1,123 | $66 |
| Telephone medical discussion with physician, 5-10 minutes | 24 | $1,085 | $45 |
| Simple insertion of temporary bladder tube | 15 | $977 | $49 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 32 | $871 | $27 |
| Injection, testosterone cypionate, 1 mg | 17 | $859 | None |
| Electronic assessment of bladder emptying | 119 | $714 | $6 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 64 | $589 | $0 |
| Blood test, basic group of blood chemicals (calcium, total) | 50 | $423 | $8 |
| Testosterone (hormone) level, total | 16 | $413 | $26 |
| Injection, tobramycin sulfate, up to 80 mg | 89 | $364 | None |
| Bacterial colony count, urine | 39 | $355 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 24 | $186 | $8 |
| Bacterial culture for aerobic isolates | 21 | $178 | $8 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 21 | $165 | $7 |
| Liver function blood test panel | 14 | $114 | $8 |
| Injection, ketorolac tromethamine, per 15 mg | 35 | $63 | None |
2021: 47 services
| Short return visit (20+ min) | 997 | $129,812 | $68 |
| Injection, denosumab, 1 mg | 14 | $79,763 | None |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 20 | $67,897 | $870 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 38 | $60,216 | $1,585 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 50 | $59,558 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 243 | $53,892 | $196 |
| New patient visit (45+ min) | 254 | $32,062 | $126 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 20 | $24,152 | $1,208 |
| Return visit (30+ min) | 131 | $14,353 | $99 |
| Ct scan of abdomen and pelvis before and after contrast | 44 | $14,150 | $314 |
| Ultrasound measurement of bladder capacity after voiding | 866 | $11,989 | $8 |
| Psa (prostate specific antigen) measurement, total | 418 | $11,414 | $18 |
| Ultrasound scan of pelvic region through rectum | 92 | $10,214 | $111 |
| Injection, degarelix, 1 mg | 13 | $9,716 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 30 | $9,507 | $307 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 25 | $7,804 | $312 |
| X-ray of body plane | 58 | $6,837 | $77 |
| Simple measurement of pressure of urine flow in bladder | 28 | $5,869 | $196 |
| Testosterone (hormone) level, total | 110 | $5,033 | $26 |
| Biopsy of prostate gland | 23 | $4,392 | $191 |
| Automated urinalysis test | 1,006 | $4,211 | $2 |
| Insertion of device into abdomen with pressure and urine flow rate study | 26 | $4,109 | $158 |
| Injection of drug or substance under skin or into muscle | 163 | $4,070 | $12 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 57 | $3,960 | $28 |
| Telephone medical discussion with physician, 11-20 minutes | 55 | $3,651 | $63 |
| Complete ultrasound scan behind abdominal cavity | 36 | $3,590 | $97 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 23 | $3,441 | $150 |
| Bacterial colony count, urine | 246 | $3,091 | $8 |
| Cell examination of specimen, concentration technique | 83 | $2,995 | $32 |
| Blood test, basic group of blood chemicals (calcium, total) | 226 | $2,869 | $8 |
| X-ray of abdomen, 1 view | 58 | $2,343 | $24 |
| Ct scan of abdomen and pelvis without contrast | 13 | $2,163 | $166 |
| Insertion of needle into vein for collection of blood sample | 461 | $2,068 | $3 |
| Simple insertion of temporary bladder tube | 18 | $1,748 | $55 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 119 | $1,632 | $8 |
| Bacterial culture for aerobic isolates | 132 | $1,616 | $8 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 132 | $1,496 | $7 |
| Liver function blood test panel | 65 | $1,234 | $8 |
| Injection, testosterone cypionate, 1 mg | 13 | $1,001 | None |
| Electronic assessment of bladder emptying | 126 | $742 | $6 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 26 | $722 | $28 |
| Short return visit | 14 | $661 | $47 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 48 | $442 | $0 |
| Injection, garamycin, gentamicin, up to 80 mg | 103 | $294 | None |
| Injection, tobramycin sulfate, up to 80 mg | 36 | $202 | None |
| Injection, ketorolac tromethamine, per 15 mg | 43 | $74 | None |
| Injection, ceftriaxone sodium, per 250 mg | 14 | $28 | None |
2020: 47 services
| Short return visit (20+ min) | 965 | $97,034 | $56 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 26 | $86,800 | $835 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 56 | $84,360 | None |
| Injection, denosumab, 1 mg | 13 | $65,526 | None |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 40 | $62,379 | $1,559 |
| Diagnostic exam of bladder and urethra using an endoscope | 268 | $52,912 | $175 |
| New patient visit (45+ min) | 263 | $32,823 | $125 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 26 | $30,880 | $1,188 |
| Ultrasound scan of pelvic region through rectum | 109 | $13,077 | $120 |
| Ultrasound measurement of bladder capacity after voiding | 871 | $11,520 | $8 |
| Telephone medical discussion with physician, 11-20 minutes | 170 | $10,956 | $60 |
| Ct scan of abdomen and pelvis before and after contrast | 38 | $10,670 | $281 |
| Return visit (30+ min) | 118 | $10,447 | $83 |
| Psa (prostate specific antigen) measurement, total | 359 | $9,957 | $18 |
| Insertion of lower leg neurostimulator electrode | 11 | $9,887 | $105 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 28 | $8,671 | $310 |
| X-ray of body plane | 62 | $7,353 | $80 |
| Biopsy of prostate gland | 28 | $4,945 | $177 |
| Automated urinalysis test | 1,112 | $4,728 | $2 |
| Testosterone (hormone) level, total | 80 | $4,507 | $25 |
| Dilation of urethra using an endoscope | 16 | $4,296 | $268 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 61 | $4,292 | $27 |
| Injection of drug or substance under skin or into muscle | 160 | $4,164 | $12 |
| Insertion of device into abdomen with pressure and urine flow rate study | 29 | $3,870 | $133 |
| Bacterial colony count, urine | 256 | $3,008 | $8 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 21 | $2,921 | $139 |
| Blood test, basic group of blood chemicals (calcium, total) | 197 | $2,575 | $8 |
| Cell examination of specimen, concentration technique | 73 | $2,477 | $29 |
| X-ray of abdomen, 1 view | 62 | $2,368 | $24 |
| Bcg live intravesical instillation, 1 mg | 11 | $2,342 | None |
| Ct scan of abdomen and pelvis without contrast | 11 | $1,898 | $173 |
| Bacterial culture for aerobic isolates | 142 | $1,765 | $8 |
| Insertion of needle into vein for collection of blood sample | 408 | $1,764 | $3 |
| Instillation of anti-cancer drug into bladder | 15 | $1,754 | $70 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 142 | $1,634 | $7 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 108 | $1,592 | $8 |
| Short return visit | 38 | $1,424 | $37 |
| Complete ultrasound scan behind abdominal cavity | 22 | $1,423 | $65 |
| Simple insertion of temporary bladder tube | 18 | $1,417 | $52 |
| Liver function blood test panel | 70 | $1,315 | $8 |
| Injection, testosterone cypionate, 1 mg | 17 | $1,051 | None |
| Electronic assessment of bladder emptying | 137 | $856 | $6 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 29 | $816 | $28 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 40 | $333 | $0 |
| Injection, garamycin, gentamicin, up to 80 mg | 118 | $319 | None |
| Injection, ceftriaxone sodium, per 250 mg | 12 | $28 | None |
| Injection, ketorolac tromethamine, per 15 mg | 13 | $27 | None |
2019: 49 services
| Short return visit (20+ min) | 1,208 | $125,887 | $53 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 27 | $98,085 | $804 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 56 | $89,515 | $1,570 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 61 | $82,084 | None |
| Injection, denosumab, 1 mg | 14 | $53,018 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 281 | $47,637 | $155 |
| New patient visit (45+ min) | 316 | $36,850 | $117 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 28 | $30,112 | $1,075 |
| Ultrasound measurement of bladder capacity after voiding | 1,107 | $20,839 | $10 |
| Psa (prostate specific antigen) measurement, total | 468 | $14,308 | $20 |
| Ultrasound scan of pelvic region through rectum | 123 | $13,996 | $107 |
| Ct scan of abdomen and pelvis before and after contrast | 47 | $13,489 | $287 |
| Return visit (30+ min) | 139 | $12,319 | $84 |
| Injection, degarelix, 1 mg | 16 | $9,438 | None |
| Complete ultrasound scan behind abdominal cavity | 102 | $9,384 | $90 |
| Automated urinalysis test | 1,383 | $7,176 | $2 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 24 | $7,049 | $294 |
| X-ray of body plane | 63 | $6,462 | $77 |
| Biopsy of prostate gland | 33 | $6,367 | $193 |
| Injection of drug or substance under skin or into muscle | 193 | $5,343 | $13 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 18 | $5,164 | $287 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 29 | $4,791 | $165 |
| Testosterone (hormone) level, total | 89 | $4,670 | $28 |
| Bacterial colony count, urine | 324 | $4,633 | $9 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 68 | $4,618 | $25 |
| Cell examination of specimen, concentration technique | 104 | $3,689 | $30 |
| Instillation of anti-cancer drug into bladder | 23 | $3,473 | $68 |
| Insertion of device into abdomen with pressure and urine flow rate study | 26 | $3,091 | $119 |
| Blood test, basic group of blood chemicals (calcium, total) | 185 | $2,838 | $9 |
| Simple change of bladder tube | 12 | $2,766 | $73 |
| Bacterial culture for aerobic isolates | 169 | $2,496 | $9 |
| Long return visit (40+ min) | 21 | $2,406 | $115 |
| Insertion of needle into vein for collection of blood sample | 525 | $2,339 | $3 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 168 | $2,125 | $8 |
| X-ray of abdomen, 1 view | 62 | $2,000 | $24 |
| Simple insertion of temporary bladder tube | 21 | $1,848 | $49 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 106 | $1,582 | $8 |
| Liver function blood test panel | 74 | $1,540 | $9 |
| Short return visit | 36 | $1,279 | $33 |
| Bcg live intravesical instillation, 1 mg | 11 | $1,218 | None |
| Injection, testosterone cypionate, 1 mg | 29 | $1,174 | None |
| Electronic assessment of bladder emptying | 150 | $938 | $6 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 28 | $798 | $29 |
| Dxa bone density measurement of hip, pelvis, spine | 18 | $766 | $43 |
| Injection, garamycin, gentamicin, up to 80 mg | 147 | $416 | None |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 48 | $413 | $0 |
| Examination of archival tissue for genetic analysis | 19 | $361 | $19 |
| Injection, ceftriaxone sodium, per 250 mg | 19 | $48 | None |
| Injection, ketorolac tromethamine, per 15 mg | 21 | $40 | None |
2018: 49 services
| Short return visit (20+ min) | 1,153 | $120,128 | $52 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 26 | $90,953 | $827 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 52 | $61,688 | None |
| Other procedure on urinary system | 30 | $49,718 | $1,604 |
| Diagnostic exam of bladder and urethra using an endoscope | 301 | $42,327 | $129 |
| Injection, denosumab, 1 mg | 12 | $41,536 | None |
| New patient visit (45+ min) | 289 | $33,295 | $115 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 26 | $27,755 | $1,067 |
| Ultrasound measurement of bladder capacity after voiding | 1,110 | $25,131 | $12 |
| Psa (prostate specific antigen) measurement, total | 434 | $15,006 | $22 |
| Ct scan of abdomen and pelvis before and after contrast | 53 | $13,330 | $252 |
| Return visit (30+ min) | 169 | $13,318 | $77 |
| Injection, degarelix, 1 mg | 14 | $8,309 | None |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 39 | $8,020 | $206 |
| Biopsy of prostate gland | 39 | $7,847 | $201 |
| Ultrasound scan of pelvic region through rectum | 88 | $7,696 | $82 |
| Automated urinalysis test | 1,321 | $7,665 | $3 |
| Creation of sling around urethra in female to control leakage | 13 | $7,394 | $569 |
| Complete ultrasound scan behind abdominal cavity | 89 | $6,828 | $75 |
| Injection of drug or substance under skin or into muscle | 154 | $6,642 | $16 |
| Bacterial colony count, urine | 363 | $5,837 | $10 |
| X-ray of body plane | 59 | $5,727 | $72 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 18 | $5,202 | $289 |
| Blood test, basic group of blood chemicals (calcium, total) | 236 | $3,864 | $10 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 57 | $3,672 | $26 |
| Cell examination of specimen, concentration technique | 99 | $3,664 | $29 |
| Bcg (intravesical) per instillation | 14 | $3,443 | None |
| Testosterone (hormone) level, total | 62 | $3,128 | $31 |
| Bacterial culture for aerobic isolates | 185 | $3,117 | $10 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 12 | $3,095 | $258 |
| Long return visit (40+ min) | 26 | $3,091 | $119 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 185 | $2,661 | $8 |
| Dilation of urethra using an endoscope | 12 | $2,613 | $218 |
| Insertion of needle into vein for collection of blood sample | 520 | $2,404 | $3 |
| Instillation of anti-cancer drug into bladder | 15 | $2,324 | $70 |
| Insertion of device into abdomen with pressure and urine flow rate study | 21 | $2,016 | $96 |
| Liver function blood test panel | 86 | $1,830 | $10 |
| X-ray of abdomen, 1 view | 58 | $1,803 | $22 |
| Injection, testosterone cypionate, 1 mg | 31 | $1,510 | None |
| Simple insertion of temporary bladder tube | 19 | $1,508 | $54 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 102 | $1,415 | $9 |
| Electronic assessment of bladder emptying | 154 | $1,081 | $7 |
| Short return visit | 28 | $1,016 | $36 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 21 | $608 | $29 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 56 | $533 | $0 |
| Dxa bone density measurement of hip, pelvis, spine | 11 | $488 | $44 |
| Injection, garamycin, gentamicin, up to 80 mg | 109 | $303 | None |
| Examination of archival tissue for genetic analysis | 15 | $296 | $20 |
| Injection, ceftriaxone sodium, per 250 mg | 14 | $33 | None |
2017: 50 services
| Short return visit (20+ min) | 1,177 | $106,426 | $49 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 56 | $67,503 | None |
| Injection, denosumab, 1 mg | 16 | $64,091 | None |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 18 | $46,750 | $766 |
| Destruction of prostate tissue using radiofrequency induced heat | 24 | $36,321 | $1,513 |
| Diagnostic exam of bladder and urethra using an endoscope | 269 | $36,103 | $122 |
| New patient visit (45+ min) | 289 | $30,928 | $107 |
| Ultrasound measurement of bladder capacity after voiding | 1,133 | $27,689 | $14 |
| Psa (prostate specific antigen) measurement, total | 492 | $17,932 | $25 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 18 | $17,878 | $993 |
| Return visit (30+ min) | 119 | $8,686 | $70 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 34 | $8,232 | $242 |
| Automated urinalysis test | 1,347 | $8,136 | $3 |
| Bacterial colony count, urine | 430 | $8,075 | $11 |
| Ct scan of abdomen and pelvis before and after contrast | 36 | $6,934 | $193 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 27 | $6,912 | $256 |
| Creation of sling around urethra in female to control leakage | 13 | $6,739 | $518 |
| Injection of drug or substance under skin or into muscle | 134 | $6,291 | $19 |
| Complete ultrasound scan behind abdominal cavity | 100 | $6,259 | $61 |
| Biopsy of prostate gland | 33 | $6,123 | $186 |
| Ultrasound scan of pelvic region through rectum | 72 | $5,236 | $72 |
| X-ray of body plane | 56 | $4,924 | $63 |
| Bacterial culture for aerobic isolates | 205 | $3,781 | $11 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 62 | $3,712 | $26 |
| Bcg (intravesical) per instillation | 13 | $3,712 | None |
| Long return visit (40+ min) | 32 | $3,509 | $106 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 205 | $3,218 | $9 |
| Cell examination of specimen, concentration technique | 93 | $3,191 | $29 |
| Dilation of urethra using an endoscope | 13 | $3,012 | $201 |
| Instillation of anti-cancer drug into bladder | 18 | $2,841 | $65 |
| Blood test, basic group of blood chemicals (calcium, total) | 193 | $2,683 | $9 |
| Insertion of needle into vein for collection of blood sample | 548 | $2,416 | $3 |
| Insertion of device into abdomen with pressure and urine flow rate study | 27 | $2,397 | $89 |
| Testosterone (hormone) level, total | 50 | $2,394 | $35 |
| Simple change of bladder tube | 12 | $1,982 | $66 |
| Ultrasonic guidance for needle placement | 35 | $1,611 | $46 |
| X-ray of abdomen, single view | 56 | $1,539 | $17 |
| Simple insertion of temporary bladder tube | 20 | $1,507 | $46 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 95 | $1,277 | $10 |
| Liver function blood test panel | 70 | $1,003 | $7 |
| Injection, testosterone cypionate, 1 mg | 24 | $963 | None |
| New patient visit (30+ min) | 17 | $872 | $51 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 28 | $760 | $27 |
| Electronic assessment of bladder emptying | 100 | $674 | $7 |
| Short return visit | 16 | $509 | $30 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 37 | $345 | $0 |
| Ultrasound scan of scrotum | 11 | $319 | $29 |
| Examination of archival tissue for genetic analysis | 15 | $275 | $18 |
| Injection, garamycin, gentamicin, up to 80 mg | 91 | $262 | None |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $25 | None |
2016: 52 services
| Short return visit (20+ min) | 1,125 | $120,079 | $52 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 63 | $84,720 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 278 | $49,117 | $164 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 15 | $41,479 | $813 |
| New patient visit (45+ min) | 270 | $32,033 | $119 |
| Injection, denosumab, 1 mg | 11 | $30,930 | None |
| Ultrasound measurement of bladder capacity after voiding | 1,090 | $30,509 | $15 |
| Return visit (30+ min) | 242 | $21,657 | $80 |
| Psa (prostate specific antigen) measurement, total | 492 | $18,591 | $24 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 15 | $15,820 | $1,055 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 41 | $12,955 | $316 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 36 | $10,025 | $278 |
| Ct scan of abdomen and pelvis before and after contrast | 47 | $9,524 | $203 |
| Automated urinalysis test | 1,331 | $8,767 | $3 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $7,641 | $695 |
| Injection of drug or substance under skin or into muscle | 126 | $6,786 | $20 |
| Creation of sling around urethra in female to control leakage | 11 | $6,408 | $583 |
| Bacterial colony count, urine | 347 | $6,000 | $11 |
| X-ray of body plane | 60 | $5,872 | $72 |
| Biopsy of prostate gland | 33 | $5,569 | $169 |
| Ultrasound scan of pelvic region through rectum | 58 | $4,633 | $76 |
| Cell examination of specimen, concentration technique | 104 | $4,472 | $36 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 64 | $4,368 | $27 |
| Long return visit (40+ min) | 34 | $4,033 | $119 |
| New patient visit (30+ min) | 46 | $3,771 | $82 |
| Insertion of device into abdomen with pressure and urine flow rate study | 38 | $3,571 | $94 |
| Instillation of anti-cancer drug into bladder | 15 | $3,509 | $90 |
| Bcg (intravesical) per instillation | 12 | $3,478 | None |
| Blood test, basic group of blood chemicals (calcium, total) | 221 | $3,253 | $9 |
| Bacterial culture for aerobic isolates | 180 | $3,193 | $11 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 39 | $3,143 | $81 |
| Simple change of bladder tube | 12 | $2,847 | $69 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 180 | $2,725 | $9 |
| Simple insertion of temporary bladder tube | 28 | $2,715 | $58 |
| Insertion of needle into vein for collection of blood sample | 564 | $2,589 | $3 |
| Dilation of urethra using an endoscope | 11 | $2,423 | $220 |
| Ultrasonic guidance for needle placement | 34 | $1,823 | $51 |
| Removal of foreskin (older than 28 days) | 11 | $1,782 | $162 |
| X-ray of abdomen, single view | 63 | $1,631 | $19 |
| Testosterone (hormone) level, total | 30 | $1,590 | $34 |
| Liver function blood test panel | 76 | $1,429 | $8 |
| Injection, testosterone cypionate, 1 mg | 21 | $1,403 | None |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 101 | $1,352 | $10 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,329 | $111 |
| Diagnostic exam of bladder and urethra using an endoscope | 19 | $1,091 | $57 |
| Complete ultrasound scan behind abdominal cavity | 20 | $997 | $50 |
| Electronic assessment of bladder emptying | 123 | $968 | $7 |
| Short return visit | 21 | $753 | $33 |
| Examination of archival tissue for genetic analysis | 26 | $492 | $19 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 49 | $486 | $0 |
| Injection, garamycin, gentamicin, up to 80 mg | 86 | $225 | None |
| Injection, ceftriaxone sodium, per 250 mg | 21 | $59 | None |
2015: 46 services
| Short return visit (20+ min) | 1,042 | $120,516 | $53 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 54 | $72,216 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 238 | $42,982 | $163 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 12 | $31,303 | $803 |
| Injection, denosumab, 1 mg | 11 | $28,093 | None |
| Ultrasound measurement of bladder capacity after voiding | 985 | $27,067 | $15 |
| New patient visit (45+ min) | 228 | $27,034 | $119 |
| Return visit (30+ min) | 273 | $23,986 | $80 |
| Psa (prostate specific antigen) measurement, total | 507 | $19,026 | $24 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 12 | $12,492 | $1,041 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 16 | $10,625 | $664 |
| Automated urinalysis test | 1,218 | $8,174 | $3 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 28 | $7,889 | $282 |
| Ct scan of abdomen and pelvis before and after contrast | 34 | $7,113 | $203 |
| Injection of drug or substance under skin or into muscle | 121 | $7,056 | $20 |
| Creation of sling around urethra in female to control leakage | 11 | $6,364 | $579 |
| Bacterial colony count, urine | 328 | $6,279 | $11 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 16 | $6,255 | $391 |
| X-ray of body plane | 57 | $5,180 | $76 |
| Cell examination of specimen, concentration technique | 84 | $4,667 | $48 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 55 | $3,955 | $27 |
| Bacterial culture for aerobic isolates | 210 | $3,816 | $11 |
| Biopsy of prostate gland | 19 | $3,277 | $172 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 210 | $3,257 | $9 |
| Ultrasound scan of pelvic region through rectum | 41 | $3,156 | $77 |
| New patient visit (30+ min) | 37 | $3,080 | $83 |
| Simple insertion of temporary bladder tube | 25 | $3,053 | $58 |
| Insertion of device into abdomen with pressure and urine flow rate study | 30 | $2,793 | $93 |
| Long return visit (40+ min) | 24 | $2,691 | $112 |
| Instillation of anti-cancer drug into bladder | 11 | $2,664 | $86 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 33 | $2,634 | $80 |
| Insertion of needle into vein for collection of blood sample | 570 | $2,535 | $3 |
| Blood test, basic group of blood chemicals (calcium, total) | 179 | $2,235 | $8 |
| Simple change of bladder tube | 14 | $1,925 | $66 |
| Testosterone (hormone) level, total | 31 | $1,790 | $34 |
| Injection, testosterone cypionate, 1 mg | 29 | $1,757 | None |
| Liver function blood test panel | 70 | $1,519 | $9 |
| X-ray of abdomen, single view | 58 | $1,395 | $19 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 72 | $1,028 | $10 |
| Ultrasonic guidance for needle placement | 20 | $985 | $49 |
| Short return visit | 18 | $634 | $35 |
| Complete ultrasound scan behind abdominal cavity | 11 | $625 | $57 |
| Electronic assessment of bladder emptying | 77 | $523 | $7 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 37 | $491 | $0 |
| Injection, garamycin, gentamicin, up to 80 mg | 70 | $244 | None |
| Injection, ceftriaxone sodium, per 250 mg | 18 | $39 | None |
2014: 46 services
| Short return visit (20+ min) | 1,172 | $129,356 | $53 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 52 | $68,535 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 231 | $40,495 | $163 |
| New patient visit (45+ min) | 273 | $34,143 | $125 |
| Ultrasound measurement of bladder capacity after voiding | 1,082 | $29,537 | $15 |
| Destruction of prostate tissue using microwave induced heat | 17 | $27,941 | $1,644 |
| Psa (prostate specific antigen) measurement, total | 652 | $22,919 | $24 |
| Return visit (30+ min) | 206 | $18,218 | $82 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 37 | $14,954 | $394 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 15 | $10,200 | $680 |
| Ct scan of abdomen and pelvis before and after contrast | 40 | $9,297 | $232 |
| Automated urinalysis test | 1,317 | $8,741 | $3 |
| X-ray of body plane | 75 | $8,541 | $78 |
| Injection of drug or substance under skin or into muscle | 138 | $8,442 | $20 |
| Creatinine level to test for kidney function or muscle injury | 820 | $8,151 | $7 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 27 | $7,521 | $279 |
| Complete ultrasound scan behind abdominal cavity | 91 | $7,485 | $81 |
| Biopsy of prostate gland | 36 | $6,436 | $174 |
| Cell examination of specimen, concentration technique | 111 | $6,052 | $46 |
| Bacterial colony count, urine | 343 | $5,990 | $11 |
| Ultrasound scan of pelvic region through rectum | 56 | $4,256 | $75 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 54 | $3,704 | $26 |
| Simple insertion of temporary bladder tube | 28 | $3,611 | $56 |
| Bacterial culture for aerobic isolates | 198 | $3,504 | $11 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 198 | $2,988 | $9 |
| Insertion of needle into vein for collection of blood sample | 703 | $2,888 | $3 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 33 | $2,704 | $82 |
| New patient visit (30+ min) | 35 | $2,684 | $77 |
| Blood test, basic group of blood chemicals (calcium, total) | 218 | $2,630 | $8 |
| Insertion of device into abdomen with pressure and urine flow rate study | 28 | $2,592 | $93 |
| Testosterone (hormone) level, total | 45 | $2,451 | $35 |
| Long return visit (40+ min) | 21 | $2,411 | $115 |
| Ultrasonic guidance for needle placement | 36 | $2,266 | $61 |
| X-ray of abdomen, single view | 77 | $2,265 | $19 |
| Instillation of anti-cancer drug into bladder | 13 | $1,862 | $89 |
| Injection, testosterone cypionate, 1 cc, 200 mg | 44 | $1,746 | None |
| Liver function blood test panel | 81 | $1,621 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 90 | $1,219 | $10 |
| Complete ultrasound scan of pelvis | 16 | $834 | $49 |
| Short return visit | 26 | $721 | $28 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 48 | $689 | $0 |
| Electronic assessment of bladder emptying | 73 | $482 | $7 |
| Examination of archival tissue for genetic analysis | 23 | $411 | $18 |
| Injection, garamycin, gentamicin, up to 80 mg | 74 | $259 | None |
| Injection, ceftriaxone sodium, per 250 mg | 33 | $86 | None |
| Manual urinalysis test with examination using microscope, non-automated | 15 | $60 | $4 |
2013: 52 services
| Short return visit (20+ min) | 1,154 | $132,900 | $52 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 50 | $69,009 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 269 | $46,309 | $158 |
| Destruction of prostate tissue using microwave induced heat | 20 | $33,813 | $1,691 |
| Ultrasound measurement of bladder capacity after voiding | 1,031 | $30,294 | $15 |
| Psa (prostate specific antigen) measurement, total | 651 | $24,090 | $25 |
| New patient visit (45+ min) | 186 | $22,952 | $123 |
| Creatinine level to test for kidney function or muscle injury | 1,198 | $20,063 | $7 |
| Return visit (30+ min) | 206 | $19,489 | $82 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 27 | $17,541 | $650 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 42 | $11,912 | $284 |
| Pathology examination of tissue using a microscope, intermediate complexity | 35 | $11,397 | $27 |
| Ct scan of abdomen and pelvis before and after contrast | 37 | $9,739 | $263 |
| Injection of drug or substance under skin or into muscle | 130 | $9,562 | $20 |
| Automated urinalysis test | 1,251 | $9,512 | $3 |
| Creation of sling around urethra in female to control leakage | 14 | $7,806 | $558 |
| X-ray of body plane | 71 | $7,602 | $82 |
| Complete ultrasound scan behind abdominal cavity | 93 | $7,562 | $80 |
| Bacterial colony count, urine | 327 | $6,827 | $11 |
| Cell examination of specimen, concentration technique | 121 | $6,523 | $44 |
| New patient visit (30+ min) | 92 | $6,424 | $70 |
| Ultrasonic guidance for needle placement | 29 | $4,872 | $168 |
| Biopsy of prostate gland | 29 | $4,735 | $163 |
| Insertion of device into abdomen with pressure and urine flow rate study | 48 | $4,483 | $93 |
| Long return visit (40+ min) | 34 | $3,971 | $110 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 52 | $3,931 | $27 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 49 | $3,903 | $80 |
| Bacterial culture for aerobic isolates | 178 | $3,719 | $11 |
| Blood test, basic group of blood chemicals (calcium, total) | 214 | $3,201 | $9 |
| Instillation of anti-cancer drug into bladder | 12 | $3,182 | $86 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 178 | $3,158 | $9 |
| Insertion of needle into vein for collection of blood sample | 698 | $3,133 | $3 |
| Ultrasound scan of pelvic region through rectum | 52 | $3,129 | $58 |
| Testosterone (hormone) level, total | 55 | $2,830 | $35 |
| Injection, testosterone cypionate, 1 cc, 200 mg | 47 | $2,296 | None |
| Simple insertion of temporary bladder tube | 21 | $2,260 | $54 |
| X-ray of abdomen, single view | 73 | $1,952 | $20 |
| Removal of foreskin (older than 28 days) | 11 | $1,533 | $139 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 12 | $1,485 | $124 |
| Liver function blood test panel | 81 | $1,435 | $7 |
| Short return visit | 41 | $1,328 | $31 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 90 | $1,296 | $11 |
| Complete ultrasound scan of pelvis | 19 | $1,063 | $56 |
| Ultrasound scan of scrotum | 12 | $925 | $77 |
| Examination of archival tissue for genetic analysis | 18 | $843 | $47 |
| Diagnostic exam of bladder and urethra using an endoscope | 12 | $734 | $61 |
| Manual urinalysis test with examination using microscope, non-automated | 126 | $585 | $4 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 42 | $535 | $0 |
| Electronic assessment of bladder emptying | 62 | $422 | $7 |
| Injection, garamycin, gentamicin, up to 80 mg | 72 | $282 | None |
| Simple timed assessment of bladder emptying | 27 | $185 | $7 |
| Injection, ceftriaxone sodium, per 250 mg | 44 | $161 | None |
Medicaid work
$4,537 in 2024
Medicaid paid $4,537 for 1,860 billed services this clinician did in 2024, up to 78 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 551 | $2,676 |
| Short return visit (20+ min) | 472 | $1,172 |
| Return visit (30+ min) | 127 | $576 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 644 | $61 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 25 | $18 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 15 | $18 |
| New patient visit (45+ min) | 13 | $16 |
| CYSTOURETHROSCOPY | 13 | $0 |
| 2024 | 1,860 | 8 | 78 | $4,537 |
| 2023 | 2,332 | 7 | 89 | $1,705 |
| 2022 | 1,162 | 5 | 60 | $1,340 |
| 2021 | 659 | 5 | 33 | $1,161 |
| 2020 | 592 | 3 | 54 | $509 |
| 2019 | 1,048 | 5 | 68 | $1,202 |
| 2018 | 2,827 | 11 | 128 | $2,381 |
See the largest Medicaid services in earlier years
2023
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 598 | $877 |
| Short return visit (20+ min) | 684 | $768 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 811 | $32 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 71 | $28 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 16 | $0 |
| New patient visit (45+ min) | 44 | $0 |
| Return visit (30+ min) | 108 | $0 |
2022
| Short return visit (20+ min) | 469 | $896 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 362 | $407 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 300 | $37 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 17 | $0 |
| New patient visit (45+ min) | 14 | $0 |
2021
| Short return visit (20+ min) | 186 | $654 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 207 | $478 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 210 | $29 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 12 | $0 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 44 | $0 |
2020
| Short return visit (20+ min) | 132 | $262 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 175 | $212 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 285 | $35 |
2019
| Short return visit (20+ min) | 257 | $722 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 303 | $425 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 42 | $34 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 386 | $22 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 60 | $0 |
2018
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 709 | $1,135 |
| Short return visit (20+ min) | 667 | $1,094 |
| CYSTOURETHROSCOPY | 92 | $95 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 930 | $52 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 106 | $4 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 206 | $0 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 13 | $0 |
| ASSAY OF PROSTATE SPECIFIC ANTIGEN TOTAL | 13 | $0 |
| Culture, bacterial; quantitative colony count, urine | 38 | $0 |
| New patient visit (45+ min) | 41 | $0 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 12 | $0 |
Drugs they prescribed that Part D paid
$907,243
Pharmacies billed $907,243 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (53 of 3,120) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
2,774 generic and 346 brand-name prescriptions · $907,243 in drug cost · 527 antibiotic prescriptions to 266 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xtandi | 22 | $277,657 | $12,621 |
| Lynparza | 11 | $171,968 | $15,633 |
| Myrbetriq | 198 | $151,908 | $767 |
| Nubeqa | 11 | $149,165 | $13,560 |
| Gemtesa | 42 | $41,723 | $993 |
See all 28 drugs
| Xtandi | 22 | $277,657 | $12,621 |
| Lynparza | 11 | $171,968 | $15,633 |
| Myrbetriq | 198 | $151,908 | $767 |
| Nubeqa | 11 | $149,165 | $13,560 |
| Gemtesa | 42 | $41,723 | $993 |
| Tamsulosin | 1,037 | $19,244 | $19 |
| Dutasteride | 349 | $18,088 | $52 |
| Premarin | 33 | $14,047 | $426 |
| Methenamine Hippurate | 68 | $6,754 | $99 |
| Estradiol | 109 | $5,940 | $54 |
| Potassium Citrate Er | 39 | $4,338 | $111 |
| Finasteride | 172 | $2,873 | $17 |
| Nitrofurantoin | 61 | $2,839 | $47 |
| Solifenacin | 17 | $2,509 | $148 |
| Testosterone | 14 | $2,398 | $171 |
| Alfuzosin Hcl Er | 114 | $2,375 | $21 |
| Nitrofurantoin Mono-Macro | 72 | $1,769 | $25 |
| Oxybutynin Chloride | 75 | $1,518 | $20 |
| Oxybutynin Chloride Er | 58 | $1,476 | $25 |
| Ciprofloxacin | 203 | $751 | $4 |
| Sulfamethoxazole-Trimethoprim | 99 | $736 | $7 |
| Clotrimazole-Betamethasone | 51 | $669 | $13 |
| Trospium Chloride | 21 | $656 | $31 |
| Hydrocodone-Acetaminophen | 51 | $464 | $9 |
| Cephalexin | 56 | $257 | $5 |
| Amoxicillin | 33 | $93 | $3 |
| Sildenafil Citrate | 12 | $70 | $6 |
| Fluconazole | 18 | $65 | $4 |
Year by year
| 2024 | 3,120 | 818 | 2% (53) | 11% | $907,243 |
| 2023 | 3,163 | 789 | 1% (44) | None | $1,485,178 |
| 2022 | 3,403 | 792 | 1% (48) | None | $1,083,915 |
| 2021 | 3,455 | 847 | 2% (70) | None | $811,181 |
| 2020 | 3,835 | 864 | 2% (60) | None | $1,020,604 |
| 2019 | 4,118 | 851 | 1% (53) | 18% | $965,959 |
| 2018 | 4,946 | 903 | 1% (62) | 18% | $1,054,913 |
| 2017 | 5,706 | 925 | 1% (64) | 18% | $873,953 |
| 2016 | 5,933 | 950 | 2% (109) | 18% | $894,723 |
| 2015 | 5,835 | 864 | 2% (86) | 28% | $576,503 |
| 2014 | 5,383 | 851 | 2% (92) | None | $497,203 |
| 2013 | 5,905 | 861 | 2% (136) | None | $458,979 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Xtandi | 40 | $617,396 | $15,435 |
| Lynparza | 16 | $277,433 | $17,340 |
| Nubeqa | 22 | $216,265 | $9,830 |
| Myrbetriq | 283 | $203,723 | $720 |
| Tamsulosin | 1,054 | $33,543 | $32 |
| Gemtesa | 26 | $23,670 | $910 |
| Dutasteride | 327 | $22,064 | $67 |
| Premarin | 33 | $15,193 | $460 |
| Estradiol | 100 | $9,615 | $96 |
| Potassium Citrate Er | 27 | $7,787 | $288 |
| Solifenacin | 28 | $6,309 | $225 |
| Finasteride | 199 | $5,776 | $29 |
| Oxybutynin Chloride Er | 105 | $5,584 | $53 |
| Methenamine Hippurate | 52 | $5,100 | $98 |
| Tolterodine Tartrate Er | 17 | $4,307 | $253 |
| Nitrofurantoin | 95 | $4,193 | $44 |
| Alfuzosin Hcl Er | 93 | $3,433 | $37 |
| Nitrofurantoin Mono-Macro | 73 | $2,843 | $39 |
| Oxybutynin Chloride | 67 | $1,956 | $29 |
| Clotrimazole-Betamethasone | 33 | $1,029 | $31 |
| Ciprofloxacin | 163 | $989 | $6 |
| Sulfamethoxazole-Trimethoprim | 63 | $544 | $9 |
| Hydrocodone-Acetaminophen | 43 | $500 | $12 |
| Cephalexin | 42 | $230 | $5 |
| Amoxicillin | 33 | $122 | $4 |
| Sildenafil Citrate | 14 | $85 | $6 |
| Fluconazole | 12 | $74 | $6 |
2022: 25 drugs
| Xtandi | 36 | $502,656 | $13,963 |
| Myrbetriq | 263 | $177,800 | $676 |
| Abiraterone Acetate | 31 | $94,715 | $3,055 |
| Tamsulosin | 1,127 | $23,789 | $21 |
| Dutasteride | 264 | $16,598 | $63 |
| Premarin | 38 | $16,391 | $431 |
| Estradiol | 127 | $14,909 | $117 |
| Oxybutynin Chloride Er | 152 | $8,904 | $59 |
| Potassium Citrate Er | 32 | $7,569 | $237 |
| Solifenacin | 35 | $5,331 | $152 |
| Finasteride | 247 | $4,969 | $20 |
| Nitrofurantoin | 120 | $4,961 | $41 |
| Trospium Chloride Er | 11 | $4,506 | $410 |
| Methenamine Hippurate | 35 | $3,101 | $89 |
| Tolterodine Tartrate Er | 14 | $2,558 | $183 |
| Alfuzosin Hcl Er | 73 | $2,056 | $28 |
| Nitrofurantoin Mono-Macro | 75 | $1,914 | $26 |
| Oxybutynin Chloride | 58 | $1,905 | $33 |
| Clotrimazole-Betamethasone | 37 | $1,516 | $41 |
| Ciprofloxacin | 172 | $900 | $5 |
| Cephalexin | 90 | $523 | $6 |
| Sulfamethoxazole-Trimethoprim | 92 | $460 | $5 |
| Hydrocodone-Acetaminophen | 48 | $455 | $9 |
| Prednisone | 32 | $246 | $8 |
| Amoxicillin | 38 | $129 | $3 |
2021: 30 drugs
| Xtandi | 25 | $329,806 | $13,192 |
| Myrbetriq | 280 | $181,823 | $649 |
| Abiraterone Acetate | 18 | $85,079 | $4,727 |
| Tamsulosin | 1,167 | $23,662 | $20 |
| Premarin | 43 | $17,843 | $415 |
| Dutasteride | 205 | $14,592 | $71 |
| Solifenacin | 71 | $11,388 | $160 |
| Estradiol | 87 | $11,253 | $129 |
| Toviaz | 23 | $9,124 | $397 |
| Finasteride | 272 | $6,709 | $25 |
| Oxybutynin Chloride Er | 132 | $6,049 | $46 |
| Potassium Citrate Er | 24 | $5,871 | $245 |
| Tolterodine Tartrate Er | 31 | $5,271 | $170 |
| Dutasteride-Tamsulosin | 12 | $3,006 | $250 |
| Nitrofurantoin | 65 | $2,674 | $41 |
| Alfuzosin Hcl Er | 57 | $2,299 | $40 |
| Nitrofurantoin Mono-Macro | 70 | $1,947 | $28 |
| Cephalexin | 188 | $1,861 | $10 |
| Oxybutynin Chloride | 56 | $1,808 | $32 |
| Ciprofloxacin | 221 | $1,076 | $5 |
| Clotrimazole-Betamethasone | 26 | $827 | $32 |
| Hydrocodone-Acetaminophen | 70 | $797 | $11 |
| Bicalutamide | 13 | $562 | $43 |
| Terazosin | 13 | $509 | $39 |
| Sulfamethoxazole-Trimethoprim | 79 | $483 | $6 |
| Doxazosin Mesylate | 17 | $254 | $15 |
| Prednisone | 17 | $164 | $10 |
| Ampicillin Trihydrate | 11 | $147 | $13 |
| Amoxicillin | 27 | $124 | $5 |
| Imipramine | 13 | $51 | $4 |
2020: 32 drugs
| Xtandi | 40 | $502,640 | $12,566 |
| Myrbetriq | 374 | $205,080 | $548 |
| Tamsulosin | 1,370 | $23,590 | $17 |
| Premarin | 48 | $19,258 | $401 |
| Dutasteride | 213 | $17,383 | $82 |
| Estradiol | 82 | $12,492 | $152 |
| Toviaz | 31 | $12,073 | $389 |
| Potassium Citrate Er | 49 | $10,375 | $212 |
| Solifenacin | 108 | $9,860 | $91 |
| Estrace | 24 | $8,553 | $356 |
| Finasteride | 304 | $5,388 | $18 |
| Tadalafil | 16 | $4,737 | $296 |
| Dutasteride-Tamsulosin | 13 | $4,206 | $324 |
| Tolterodine Tartrate Er | 32 | $4,042 | $126 |
| Oxybutynin Chloride Er | 71 | $3,588 | $51 |
| Nitrofurantoin Mono-Macro | 86 | $2,891 | $34 |
| Nitrofurantoin | 66 | $1,885 | $29 |
| Alfuzosin Hcl Er | 48 | $1,630 | $34 |
| Cephalexin | 192 | $1,568 | $8 |
| Silodosin | 12 | $1,365 | $114 |
| Ciprofloxacin | 217 | $1,004 | $5 |
| Oxybutynin Chloride | 41 | $887 | $22 |
| Bicalutamide | 13 | $821 | $63 |
| Sulfamethoxazole-Trimethoprim | 81 | $520 | $6 |
| Clotrimazole-Betamethasone | 19 | $506 | $27 |
| Hydrocodone-Acetaminophen | 57 | $494 | $9 |
| Terazosin | 14 | $477 | $34 |
| Doxazosin Mesylate | 16 | $289 | $18 |
| Amoxicillin | 35 | $170 | $5 |
| Ampicillin Trihydrate | 12 | $154 | $13 |
| Fluconazole | 14 | $142 | $10 |
| Imipramine | 13 | $103 | $8 |
2019: 31 drugs
| Xtandi | 47 | $571,735 | $12,165 |
| Myrbetriq | 339 | $156,896 | $463 |
| Vesicare | 100 | $55,426 | $554 |
| Tamsulosin | 1,578 | $30,190 | $19 |
| Premarin | 60 | $23,223 | $387 |
| Dutasteride | 240 | $19,823 | $83 |
| Rapaflo | 24 | $10,054 | $419 |
| Potassium Citrate Er | 36 | $8,756 | $243 |
| Estradiol | 42 | $8,336 | $198 |
| Estrace | 22 | $7,663 | $348 |
| Finasteride | 363 | $7,504 | $21 |
| Solifenacin | 63 | $7,359 | $117 |
| Dutasteride-Tamsulosin | 18 | $5,960 | $331 |
| Tadalafil | 19 | $4,981 | $262 |
| Nitrofurantoin Mono-Macro | 89 | $4,189 | $47 |
| Toviaz | 11 | $3,659 | $333 |
| Bicalutamide | 50 | $1,861 | $37 |
| Oxybutynin Chloride Er | 38 | $1,836 | $48 |
| Oxybutynin Chloride | 82 | $1,781 | $22 |
| Alfuzosin Hcl Er | 55 | $1,639 | $30 |
| Nitrofurantoin | 59 | $1,618 | $27 |
| Cephalexin | 168 | $1,300 | $8 |
| Ciprofloxacin | 182 | $1,105 | $6 |
| Clotrimazole-Betamethasone | 33 | $751 | $23 |
| Sulfamethoxazole-Trimethoprim | 79 | $561 | $7 |
| Hydrocodone-Acetaminophen | 51 | $532 | $10 |
| Doxazosin Mesylate | 15 | $416 | $28 |
| Terazosin | 12 | $220 | $18 |
| Amoxicillin | 33 | $181 | $5 |
| Lorazepam | 85 | $120 | $1 |
| Paroxetine | 11 | $89 | $8 |
2018: 33 drugs
| Xtandi | 45 | $496,264 | $11,028 |
| Zytiga | 13 | $133,698 | $10,284 |
| Vesicare | 257 | $117,905 | $459 |
| Myrbetriq | 204 | $88,306 | $433 |
| Tamsulosin | 2,013 | $43,186 | $21 |
| Rapaflo | 44 | $24,362 | $554 |
| Premarin | 62 | $22,376 | $361 |
| Dutasteride | 337 | $21,028 | $62 |
| Estrace | 42 | $13,405 | $319 |
| Elmiron | 12 | $12,916 | $1,076 |
| Potassium Citrate Er | 41 | $11,126 | $271 |
| Cialis | 23 | $9,739 | $423 |
| Finasteride | 533 | $7,760 | $15 |
| Dutasteride-Tamsulosin | 24 | $6,817 | $284 |
| Estradiol | 22 | $5,158 | $234 |
| Nitrofurantoin Mono-Macro | 123 | $4,628 | $38 |
| Bicalutamide | 90 | $2,456 | $27 |
| Nitrofurantoin | 75 | $2,330 | $31 |
| Alfuzosin Hcl Er | 68 | $2,132 | $31 |
| Oxybutynin Chloride | 89 | $1,678 | $19 |
| Oxybutynin Chloride Er | 31 | $1,285 | $41 |
| Ciprofloxacin | 183 | $1,198 | $7 |
| Doxazosin Mesylate | 27 | $925 | $34 |
| Cephalexin | 127 | $737 | $6 |
| Clotrimazole-Betamethasone | 26 | $658 | $25 |
| Sulfamethoxazole-Trimethoprim | 101 | $623 | $6 |
| Hydrocodone-Acetaminophen | 53 | $574 | $11 |
| Terazosin | 33 | $290 | $9 |
| Megestrol Acetate | 12 | $202 | $17 |
| Amoxicillin | 30 | $150 | $5 |
| Prednisone | 15 | $130 | $9 |
| Lorazepam | 36 | $73 | $2 |
| Alprazolam | 27 | $38 | $1 |
2017: 37 drugs
| Xtandi | 33 | $344,898 | $10,451 |
| Myrbetriq | 264 | $99,566 | $377 |
| Vesicare | 266 | $96,927 | $364 |
| Tamsulosin | 2,291 | $54,108 | $24 |
| Rapaflo | 100 | $38,586 | $386 |
| Dutasteride | 468 | $23,159 | $49 |
| Premarin | 49 | $17,413 | $355 |
| Elmiron | 23 | $17,276 | $751 |
| Androgel | 19 | $15,634 | $823 |
| Estrace | 50 | $14,691 | $294 |
| Cialis | 23 | $12,645 | $550 |
| Finasteride | 714 | $8,957 | $13 |
| Dutasteride-Tamsulosin | 41 | $7,867 | $192 |
| Potassium Citrate Er | 27 | $5,999 | $222 |
| Nitrofurantoin Mono-Macro | 151 | $5,957 | $39 |
| Darifenacin Er | 12 | $3,447 | $287 |
| Bicalutamide | 119 | $3,188 | $27 |
| Nitrofurantoin | 61 | $2,085 | $34 |
| Alfuzosin Hcl Er | 63 | $1,459 | $23 |
| Oxybutynin Chloride | 77 | $1,318 | $17 |
| Doxazosin Mesylate | 58 | $1,272 | $22 |
| Oxybutynin Chloride Er | 19 | $1,025 | $54 |
| Ciprofloxacin | 153 | $996 | $7 |
| Sulfamethoxazole-Trimethoprim | 179 | $884 | $5 |
| Testosterone Cypionate | 13 | $767 | $59 |
| Hydrocodone-Acetaminophen | 59 | $647 | $11 |
| Betamethasone Dipropionate | 11 | $504 | $46 |
| Cephalexin | 98 | $474 | $5 |
| Clotrimazole-Betamethasone | 17 | $357 | $21 |
| Megestrol Acetate | 15 | $309 | $21 |
| Terazosin | 23 | $254 | $11 |
| Imipramine | 12 | $173 | $14 |
| Levofloxacin | 11 | $126 | $11 |
| Amoxicillin | 22 | $109 | $5 |
| Prednisone | 12 | $77 | $6 |
| Alprazolam | 40 | $69 | $2 |
| Sodium Chloride | 11 | $33 | $3 |
2016: 35 drugs
| Xtandi | 47 | $425,158 | $9,046 |
| Vesicare | 310 | $99,078 | $320 |
| Tamsulosin | 2,296 | $69,434 | $30 |
| Myrbetriq | 152 | $52,048 | $342 |
| Premarin | 147 | $44,970 | $306 |
| Rapaflo | 146 | $39,031 | $267 |
| Dutasteride | 410 | $23,091 | $56 |
| Estrace | 57 | $16,158 | $283 |
| Cialis | 33 | $14,781 | $448 |
| Androgel | 16 | $12,873 | $805 |
| Finasteride | 708 | $9,080 | $13 |
| Elmiron | 13 | $8,795 | $677 |
| Dutasteride-Tamsulosin | 31 | $5,510 | $178 |
| Avodart | 27 | $5,045 | $187 |
| Enablex | 12 | $4,941 | $412 |
| Nitrofurantoin Mono-Macro | 108 | $4,671 | $43 |
| Bicalutamide | 157 | $3,176 | $20 |
| Doxazosin Mesylate | 106 | $2,339 | $22 |
| Oxybutynin Chloride | 132 | $2,299 | $17 |
| Potassium Citrate Er | 16 | $2,264 | $141 |
| Ciprofloxacin | 219 | $1,684 | $8 |
| Nitrofurantoin | 49 | $1,565 | $32 |
| Sulfamethoxazole-Trimethoprim | 219 | $1,496 | $7 |
| Hydrocodone-Acetaminophen | 105 | $1,293 | $12 |
| Oxybutynin Chloride Er | 32 | $1,142 | $36 |
| Alfuzosin Hcl Er | 46 | $744 | $16 |
| Clotrimazole-Betamethasone | 17 | $523 | $31 |
| Cephalexin | 72 | $418 | $6 |
| Testosterone Cypionate | 11 | $413 | $38 |
| Imipramine | 18 | $231 | $13 |
| Amoxicillin | 15 | $118 | $8 |
| Megestrol Acetate | 14 | $114 | $8 |
| Fluconazole | 11 | $100 | $9 |
| Alprazolam | 26 | $64 | $2 |
| Sertraline | 11 | $51 | $5 |
2015: 34 drugs
| Avodart | 534 | $103,867 | $195 |
| Zytiga | 12 | $91,775 | $7,648 |
| Tamsulosin | 2,135 | $73,686 | $35 |
| Rapaflo | 282 | $66,243 | $235 |
| Vesicare | 235 | $63,838 | $272 |
| Premarin | 205 | $52,668 | $257 |
| Myrbetriq | 92 | $26,104 | $284 |
| Cialis | 55 | $15,942 | $290 |
| Dutasteride | 68 | $10,822 | $159 |
| Finasteride | 680 | $9,107 | $13 |
| Jalyn | 33 | $6,746 | $204 |
| Enablex | 17 | $6,007 | $353 |
| Estrace | 21 | $5,446 | $259 |
| Nitrofurantoin Mono-Macro | 111 | $5,273 | $48 |
| Doxazosin Mesylate | 156 | $4,040 | $26 |
| Toviaz | 14 | $3,096 | $221 |
| Bicalutamide | 133 | $2,816 | $21 |
| Potassium Citrate Er | 14 | $2,225 | $159 |
| Oxybutynin Chloride Er | 36 | $1,757 | $49 |
| Ciprofloxacin | 215 | $1,715 | $8 |
| Oxybutynin Chloride | 93 | $1,680 | $18 |
| Sulfamethoxazole-Trimethoprim | 216 | $1,340 | $6 |
| Hydrocodone-Acetaminophen | 61 | $1,195 | $20 |
| Alfuzosin Hcl Er | 75 | $1,021 | $14 |
| Nitrofurantoin | 26 | $822 | $32 |
| Clotrimazole-Betamethasone | 13 | $444 | $34 |
| Imipramine | 24 | $395 | $16 |
| Megestrol Acetate | 19 | $275 | $14 |
| Cephalexin | 37 | $216 | $6 |
| Prednisone | 12 | $126 | $11 |
| Levofloxacin | 15 | $126 | $8 |
| Amoxicillin | 24 | $118 | $5 |
| Acetaminophen-Codeine | 15 | $91 | $6 |
| Alprazolam | 20 | $83 | $4 |
2014: 32 drugs
| Avodart | 748 | $127,572 | $171 |
| Vesicare | 254 | $59,571 | $235 |
| Premarin | 259 | $55,941 | $216 |
| Nilandron | 12 | $51,859 | $4,322 |
| Rapaflo | 275 | $50,165 | $182 |
| Tamsulosin | 1,940 | $43,237 | $22 |
| Myrbetriq | 26 | $8,626 | $332 |
| Jalyn | 49 | $8,465 | $173 |
| Nitrofurantoin Mono-Macro | 146 | $8,162 | $56 |
| Cialis | 39 | $7,643 | $196 |
| Androgel | 11 | $7,302 | $664 |
| Finasteride | 489 | $6,996 | $14 |
| Toviaz | 19 | $3,836 | $202 |
| Doxazosin Mesylate | 143 | $3,532 | $25 |
| Enablex | 11 | $3,311 | $301 |
| Estrace | 11 | $2,625 | $239 |
| Bicalutamide | 76 | $2,619 | $34 |
| Oxybutynin Chloride Er | 32 | $2,311 | $72 |
| Ciprofloxacin | 194 | $1,500 | $8 |
| Hydrocodone-Acetaminophen | 71 | $1,423 | $20 |
| Oxybutynin Chloride | 68 | $1,230 | $18 |
| Clotrimazole-Betamethasone | 20 | $1,103 | $55 |
| Sulfamethoxazole-Trimethoprim | 142 | $1,035 | $7 |
| Nitrofurantoin | 20 | $915 | $46 |
| Vicodin | 11 | $487 | $44 |
| Alfuzosin Hcl Er | 27 | $455 | $17 |
| Cephalexin | 37 | $341 | $9 |
| Terazosin | 38 | $253 | $7 |
| Imipramine | 16 | $247 | $15 |
| Sertraline | 12 | $103 | $9 |
| Amoxicillin | 14 | $85 | $6 |
| Trazodone | 11 | $75 | $7 |
2013: 31 drugs
| Avodart | 741 | $114,565 | $155 |
| Vesicare | 381 | $80,929 | $212 |
| Rapaflo | 290 | $48,402 | $167 |
| Tamsulosin | 2,112 | $38,283 | $18 |
| Premarin | 200 | $38,078 | $190 |
| Nilandron | 12 | $23,944 | $1,995 |
| Finasteride | 512 | $10,470 | $20 |
| Androgel | 18 | $10,202 | $567 |
| Jalyn | 53 | $9,252 | $175 |
| Nitrofurantoin Mono-Macro | 125 | $6,964 | $56 |
| Estrace | 30 | $4,325 | $144 |
| Detrol La | 20 | $4,305 | $215 |
| Toviaz | 22 | $3,738 | $170 |
| Enablex | 20 | $3,547 | $177 |
| Bicalutamide | 57 | $3,450 | $61 |
| Cialis | 21 | $3,175 | $151 |
| Doxazosin Mesylate | 222 | $3,083 | $14 |
| Ciprofloxacin | 266 | $2,231 | $8 |
| Oxybutynin Chloride | 117 | $1,496 | $13 |
| Sulfamethoxazole-Trimethoprim | 149 | $1,379 | $9 |
| Desmopressin Acetate | 12 | $1,218 | $102 |
| Clotrimazole-Betamethasone | 14 | $973 | $69 |
| Alfuzosin | 35 | $964 | $28 |
| Nitrofurantoin | 22 | $854 | $39 |
| Hydrocodone-Acetaminophen | 124 | $631 | $5 |
| Levofloxacin | 16 | $539 | $34 |
| Imipramine | 33 | $423 | $13 |
| Cephalexin | 47 | $411 | $9 |
| Terazosin | 30 | $221 | $7 |
| Paroxetine | 13 | $121 | $9 |
| Amoxicillin | 15 | $86 | $6 |
Money from drug and device companies
$1,781 in 2025
| 2025 | 18 | 53 | None | $1,781 |
| 2024 | 17 | 41 | None | $2,132 |
| 2023 | 13 | 26 | None | $1,429 |
| 2022 | 15 | 24 | None | $603 |
| 2021 | 9 | 21 | None | $355 |
| 2020 | 5 | 11 | None | $178 |
| 2019 | 12 | 44 | None | $1,052 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Padcev | $410 | 6 payments
|
| Teleflex | Barrigel | $203 | 7 payments
|
| Dendreon Pharmaceuticals | Provenge | $196 | 4 payments
|
| Janssen Biotech | Erleada | $193 | 5 payments
|
| Pfizer | Xtandi | $155 | 7 payments
|
| Sumitomo Pharma America | Orgovyx | $85 | 4 payments
|
See all 53 published payments
| Dendreon Pharmaceuticals | Meals · 2025-12-17 | Provenge | $25 |
| Sumitomo Pharma America | Meals · 2025-12-08 | Orgovyx | $23 |
| AstraZeneca Pharmaceuticals LP | Education · 2025-11-19 | Imfinzi | $35 |
| Janssen Biotech | Meals · 2025-11-16 | Erleada | $31 |
| Teleflex | Meals · 2025-11-14 | Urolift | $30 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-11 | Nubeqa | $23 |
| Novartis Pharmaceuticals | Meals · 2025-11-06 | Pluvicto | $21 |
| Astellas Pharma US | Meals · 2025-11-05 | Padcev | $115 |
| Dendreon Pharmaceuticals | Meals · 2025-11-04 | Provenge | $145 |
| Janssen Biotech | Education · 2025-10-16 | Erleada | $90 |
| Astellas Pharma US | Meals · 2025-10-09 | Xtandi | $4 |
| Dendreon Pharmaceuticals | Meals · 2025-10-08 | Provenge | $10 |
| Teleflex | Meals · 2025-10-07 | Urolift | $21 |
| Caris MPI | Meals · 2025-10-06 | Mi Cancer Seek | $27 |
| Janssen Biotech | Meals · 2025-09-22 | Erleada | $25 |
| Astellas Pharma US | Education · 2025-09-03 | None | $99 |
| Pfizer | Meals · 2025-09-02 | Xtandi | $24 |
| Teleflex | Meals · 2025-08-28 | Urolift | $43 |
| Antares Pharma | Meals · 2025-08-21 | Xyosted | $19 |
| Astellas Pharma US | Education · 2025-08-21 | None | $68 |
| Boston Scientific | Meals · 2025-08-20 | Lithovue | $43 |
| Astellas Pharma US | Education · 2025-08-14 | None | $99 |
| Teleflex | Meals · 2025-08-13 | Barrigel | $27 |
| Novartis Pharmaceuticals | Meals · 2025-08-05 | Pluvicto | $32 |
| Caris MPI | Meals · 2025-07-30 | Mi Cancer Seek | $23 |
| Sumitomo Pharma America | Meals · 2025-07-27 | Gemtesa | $23 |
| Teleflex | Meals · 2025-07-24 | Barrigel | $44 |
| Endo USA | Meals · 2025-07-23 | Aveed | $25 |
| Tempus AI | Meals · 2025-07-22 | Xt Cdx | $25 |
| Pfizer | Meals · 2025-07-17 | Xtandi | $19 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-14 | Nubeqa | $21 |
| Antares Pharma | Meals · 2025-06-30 | Xyosted | $23 |
| Dendreon Pharmaceuticals | Meals · 2025-06-28 | Provenge | $17 |
| Teleflex | Meals · 2025-06-25 | Barrigel | $23 |
| Pfizer | Meals · 2025-06-06 | Xtandi | $10 |
| Sumitomo Pharma America | Meals · 2025-06-03 | Orgovyx | $17 |
| Caris MPI | Meals · 2025-06-03 | Mi Cancer Seek | $27 |
| Teleflex | Meals · 2025-05-23 | Barrigel | $16 |
| Pfizer | Meals · 2025-05-14 | Xtandi | $30 |
| Progenics Pharmaceuticals | Meals · 2025-05-14 | Pylarify | $23 |
| Profound Medical | Meals · 2025-05-12 | Tulsa-Pro | $27 |
| Ferring Pharmaceuticals | Meals · 2025-05-09 | Adstiladrin | $45 |
| Astellas Pharma US | Meals · 2025-04-25 | Xtandi | $25 |
| Abbvie | Meals · 2025-04-15 | Lupron Depot | $25 |
| Novartis Pharmaceuticals | Meals · 2025-04-11 | Pluvicto | $30 |
| Endo USA | Meals · 2025-04-09 | Xiaflex | $18 |
| Janssen Biotech | Meals · 2025-04-08 | Erleada | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-01 | Nubeqa | $25 |
| Janssen Biotech | Meals · 2025-03-28 | Erleada | $18 |
| Pfizer | Meals · 2025-03-25 | Xtandi | $24 |
| Sumitomo Pharma America | Meals · 2025-03-17 | Orgovyx | $22 |
| Pfizer | Meals · 2025-02-25 | Xtandi | $24 |
| Pfizer | Meals · 2025-01-27 | Xtandi | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,132
| Teleflex | Urolift | $1,197 | 7 payments
|
| Janssen Biotech | Erleada | $376 | 8 payments
|
| Sumitomo Pharma America | Gemtesa | $74 | 3 payments
|
| Ferring Pharmaceuticals | Adstiladrin | $74 | 3 payments
|
| Boston Scientific | Spaceoar Vue System - 10ml | $69 | 2 payments
|
| Coloplast | Coloplast Tfl Drive | $50 | 2 payments
|
| Olympus America | Itind System | $44 | 2 payments
|
| Abbvie | Botox | $31 | 1 payment
|
| Laborie Medical Technologies | Optilume Bph Drug Coated Balloon Catheter | $30 | 1 payment
|
| Novartis Pharmaceuticals | Pluvicto | $29 | 1 payment
|
| Tempus AI | None | $28 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $24 | 1 payment
|
| Urogen Pharma | Jelmyto | $24 | 1 payment
|
| Dendreon Pharmaceuticals | Provenge | $23 | 1 payment
|
| Pfizer | Xtandi | $22 | 1 payment
|
| Immunitybio | Anktiva | $20 | 1 payment
|
| Accord Healthcare | Camcevi | $17 | 1 payment
|
2023: $1,429
| Teleflex | Urolift | $468 | 2 payments
|
| Janssen Biotech | Erleada | $264 | 5 payments
|
| Endo Pharmaceuticals | Xiaflex | $157 | 1 payment
|
| Supernus Pharmaceuticals | Xyosted | $103 | 4 payments
|
| Astellas Pharma US | None | $89 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $65 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $63 | 1 payment
|
| Olympus America | Itind System | $54 | 2 payments
|
| Pfizer | Xtandi | $45 | 2 payments
|
| Coloplast | Altis | $38 | 2 payments
|
| Boston Scientific | Spaceoar Vue System - 10ml | $36 | 1 payment
|
| Accord Healthcare | Camcevi | $26 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $21 | 1 payment
|
2022: $603
| Janssen Biotech | Erleada | $149 | 4 payments
|
| Myovant Sciences | Orgovyx | $68 | 3 payments
|
| Urovant Sciences | Gemtesa | $61 | 3 payments
|
| Merck Sharp & Dohme | Keytruda | $44 | 1 payment
|
| Antares Pharma | Nocdurna | $44 | 1 payment
|
| TOLMAR Pharmaceuticals | Eligard | $38 | 2 payments
|
| Amgen | Xgeva | $31 | 1 payment
|
| Coloplast | Altis | $28 | 2 payments
|
| Progenics Pharmaceuticals | Pylarify | $28 | 1 payment
|
| Teleflex | Urolift System | $24 | 1 payment
|
| Accord Healthcare | Camcevi | $24 | 1 payment
|
| Olympus America | Itind System | $20 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $16 | 1 payment
|
| Astellas Pharma US | Xtandi | $15 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $14 | 1 payment
|
2021: $355
| Boston Scientific | General Bph | $115 | 7 payments
|
| Astellas Pharma US | Xtandi | $66 | 4 payments
|
| Myovant Sciences | Orgovyx | $38 | 2 payments
|
| Endo Pharmaceuticals | Xiaflex | $35 | 2 payments
|
| Coloplast | Speedicath | $33 | 2 payments
|
| Pfizer | Xtandi | $22 | 1 payment
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $18 | 1 payment
|
| Dendreon Pharmaceuticals | Provenge | $15 | 1 payment
|
| Teleflex | Urolift System | $14 | 1 payment
|
2020: $178
| Boston Scientific | General - Bph | $106 | 6 payments
|
| Astellas Pharma US | Xtandi | $25 | 2 payments
|
| TOLMAR Pharmaceuticals | Eligard | $19 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $16 | 1 payment
|
| Allergan | Botox | $12 | 1 payment
|
2019: $1,052
| Astellas Pharma US | Xtandi | $297 | 18 payments
|
| Coloplast | Titan | $236 | 6 payments
|
| Boston Scientific | General Bph | $151 | 6 payments
|
| NeoTract | Urolift | $103 | 3 payments
|
| Allergan | Botox | $90 | 1 payment
|
| Medtronic USA | Interstim Icon | $70 | 2 payments
|
| Janssen Biotech | Erleada | $30 | 2 payments
|
| Ferring Pharmaceuticals | Firmagon | $27 | 2 payments
|
| Avadel Specialty Pharmaceuticals | Noctiva | $14 | 1 payment
|
| Pfizer | Xtandi | $13 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Xofigo | $12 | 1 payment
|
| Blue Earth Diagnostics | Axumin | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 79.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1356346365
- Licence
- CA A395860
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A395860
- Taxonomy
- Urology (208800000X)
- Mailing address
- 7014 N Whitney Ave, Ste A, Fresno, CA, 93720
- NPI first listed
- 2005-06-16
- NPI last updated
- 2013-12-31
This is when the NPI record was last certified, not a medical board exam.